Aimmune pushes the boundaries of medicine to help reduce the burden of serious and potentially life-threatening food, gastrointestinal (GI), and metabolic-related diseases — enabling people to live life on their own terms.
We're on a mission to transform the lives of patients and their families
by developing pharmaceutical therapies to prevent, manage,
and treat food, GI, and metabolic-related diseases.
ABOUT AIMMUNE
Taking Aim at Food, GI, and Metabolic-Related Diseases
Aimmune Therapeutics, a Nestlé Health Science company, is a biopharmaceutical company that aspires to be a global leader in developing innovative medicines to treat, prevent, and manage food, GI, and metabolic-related diseases for those with few or no treatment options. Aimmune was built on the belief that families deserve standardized, regulatory-approved, science-driven treatments that
reduce their daily burden and help them better manage these conditions.
Recent News
PIPELINE
See the Future
We’re uniting the best minds across clinical research and biotechnology to develop therapies for serious and potentially life-threatening food, GI, and metabolic-related diseases, and you’re invited to see where we’re headed.
CAREERS
Join Our Team
We’re building a team that aims to transform the lives of patients and their families by developing pharmaceutical therapies to prevent, manage, and treat food, GI, and metabolic-related diseases. Learn more about our company and explore current openings.